Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Pompholyx and hand eczema

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Urgently assess a painful swollen hand with rapidly spreading erythema, fever, lymphangitis, deep-space concern or monomorphic herpetic erosions because infection can threaten hand function.

Synopsis

Recognise vesicular pompholyx within the broader hand-eczema phenotype, identify fungal, contact and occupational contributors, and restore function with protection and site-appropriate treatment.

  • Pompholyx causes intensely itchy deep-seated vesicles on palms and finger sides, followed by peeling, fissures and sometimes secondary infection.
  • Hand-eczema shape does not reveal cause; atopy, wet work, allergic contact and dermatophyte infection frequently overlap.
  • Ask about every task, hand-wash, sanitiser, glove material, hobby and product, plus improvement away from work and foot or nail fungus.
  • Use frequent emollient and soap substitution, reduce wet work, and select protective gloves for the actual chemical with cotton liners for prolonged wear.
  • Palmar skin often needs a potent topical corticosteroid for a defined course; very-potent treatment or occlusion should be supervised and short.
  • Unilateral scale, grouped painful digit vesicles or loss of movement should trigger tinea, herpes or deep infection assessment.
  • For Pompholyx and hand eczema, document body sites, severity, sleep and function, recent treatment, infection features and what the patient can realistically apply each day.
  • In Pompholyx and hand eczema, reassess the diagnosis when a well-used, correctly potent regimen fails rather than repeatedly intensifying treatment without examining adherence, exposure and mimics.

Key red flags

Severe pain, reduced movement, fever, spreading cellulitis, clustered painful erosions, extensive bullae, occupational incapacity or persistent unilateral disease requires urgent or specialist review.

Deep infection warning

Progressive pain, swelling, limited movement, lymphangitis or fever requires urgent assessment beyond superficial eczema care.

Investigation priorities

01
Structured task and glove historyFirst step

Quantify wet work, chemical contact, occlusion and periods of improvement.

Management branches

Acute vesicular flareSettle inflammation and preserve barrier

Symmetrical itchy palm or finger-side vesicles occur without fever, focal herpes or deep infection.

  1. Use cool wet compresses briefly for weeping, then a frequent bland emollient and soap substitute while protecting fissures.
  2. Apply a potent palmar topical corticosteroid once or twice daily for a defined licensed course, using very-potent escalation only under supervision.
  3. Reduce wet work and sweat occlusion and review within two to four weeks for new vesicles, fissure closure and function.

Key medicines

Betamethasone valerate 0.1% creamApply a thin film to active hand skin once or twice daily for up to four weeks, reducing or stopping when inflammation is controlled.Avoid untreated infection and unplanned occlusion; review atrophy, total quantity and response, and investigate tinea or allergy when disease persists.
Clobetasol propionate 0.05% ointmentAdults apply thinly once or twice daily only to resistant thick palmar plaques for a short specialist-directed course not exceeding four weeks or 50 g weekly.Do not use on face, untreated infection or widespread skin; avoid prolonged occlusion, monitor local and systemic toxicity, and step down promptly with response.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Association of Dermatologists hand dermatitisWet-work risks, morphology, patch testing and protection.
  • British Association of Dermatologists patch testingDelayed contact-allergy test preparation and interpretation.
  • NICE NG190 secondary bacterial infection of eczemaAntibiotic thresholds, choice, duration and reassessment.
  • Betamethasone valerate 0.1 percent cream SmPCPotent topical corticosteroid regimen and safeguards.
  • Clobetasol propionate 0.05 percent ointment SmPCVery potent corticosteroid limits and safety requirements.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom